These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 27647871)

  • 1. Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.
    Sharma-Chawla N; Sender V; Kershaw O; Gruber AD; Volckmar J; Henriques-Normark B; Stegemann-Koniszewski S; Bruder D
    Infect Immun; 2016 Dec; 84(12):3445-3457. PubMed ID: 27647871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus.
    Chen YY; Huang CT; Li SW; Pan YJ; Lin TL; Huang YY; Li TH; Yang YC; Gong YN; Hsieh YC
    J Biomed Sci; 2021 Aug; 28(1):60. PubMed ID: 34452635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filamentous influenza A virus infection predisposes mice to fatal septicemia following superinfection with Streptococcus pneumoniae serotype 3.
    Speshock JL; Doyon-Reale N; Rabah R; Neely MN; Roberts PC
    Infect Immun; 2007 Jun; 75(6):3102-11. PubMed ID: 17403870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal conjugate vaccine modulates macrophage-mediated innate immunity in pneumonia caused by Streptococcus pneumoniae following influenza.
    Mimura K; Kimura S; Kajiwara C; Nakakubo S; Schaller MA; Ishii Y; Standiford TJ; Kunkel SL; Tateda K
    Microbes Infect; 2020 Sep; 22(8):312-321. PubMed ID: 31958572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteinyl Maresins Reprogram Macrophages to Protect Mice from Streptococcus pneumoniae after Influenza A Virus Infection.
    P Tavares L; Brüggemann TR; M Rezende R; G Machado M; Cagnina RE; Shay AE; C Garcia C; Nijmeh J; M Teixeira M; Levy BD
    mBio; 2022 Aug; 13(4):e0126722. PubMed ID: 35913160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune responses at the asymptomatic stage of influenza A viral infections of Streptococcus pneumoniae colonized and non-colonized mice.
    Cuypers F; Schäfer A; Skorka SB; Surabhi S; Tölken LA; Paulikat AD; Kohler TP; Otto SA; Mettenleiter TC; Hammerschmidt S; Blohm U; Siemens N
    Sci Rep; 2021 Oct; 11(1):20609. PubMed ID: 34663857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age.
    Joma BH; Siwapornchai N; Vanguri VK; Shrestha A; Roggensack SE; Davidson BA; Tai AK; Hakansson AP; Meydani SN; Leong JM; Bou Ghanem EN
    Infect Immun; 2021 Jul; 89(8):e0047120. PubMed ID: 34031128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
    Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
    mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.
    Kash JC; Walters KA; Davis AS; Sandouk A; Schwartzman LM; Jagger BW; Chertow DS; Li Q; Kuestner RE; Ozinsky A; Taubenberger JK
    mBio; 2011; 2(5):. PubMed ID: 21933918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I Interferon Signaling Is a Common Factor Driving Streptococcus pneumoniae and Influenza A Virus Shedding and Transmission.
    Zangari T; Ortigoza MB; Lokken-Toyli KL; Weiser JN
    mBio; 2021 Feb; 12(1):. PubMed ID: 33593970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection.
    Kosai K; Seki M; Tanaka A; Morinaga Y; Imamura Y; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Tomono K; Kohno S
    Jpn J Infect Dis; 2011; 64(6):451-7. PubMed ID: 22116322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against Streptococcus pneumoniae Invasive Pathogenesis by a Protein-Based Vaccine Is Achieved by Suppression of Nasopharyngeal Bacterial Density during Influenza A Virus Coinfection.
    Khan MN; Xu Q; Pichichero ME
    Infect Immun; 2017 Feb; 85(2):. PubMed ID: 27895132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Perfect Storm: Increased Colonization and Failure of Vaccination Leads to Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice.
    Karlsson EA; Meliopoulos VA; van de Velde NC; van de Velde LA; Mann B; Gao G; Rosch J; Tuomanen E; McCullers J; Vogel P; Schultz-Cherry S
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-Like Receptor 3/TRIF-Dependent IL-12p70 Secretion Mediated by Streptococcus pneumoniae RNA and Its Priming by Influenza A Virus Coinfection in Human Dendritic Cells.
    Spelmink L; Sender V; Hentrich K; Kuri T; Plant L; Henriques-Normark B
    mBio; 2016 Mar; 7(2):e00168-16. PubMed ID: 26956584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergism and Antagonism of Bacterial-Viral Coinfection in the Upper Respiratory Tract.
    Manna S; McAuley J; Jacobson J; Nguyen CD; Ullah MA; Sebina I; Williamson V; Mulholland EK; Wijburg O; Phipps S; Satzke C
    mSphere; 2022 Feb; 7(1):e0098421. PubMed ID: 35044807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the complement C5a receptor alleviates the severity of acute pneumococcal otitis media following influenza A virus infection in mice.
    Tong HH; Lambert G; Li YX; Thurman JM; Stahl GL; Douthitt K; Clancy C; He Y; Bowman AS
    PLoS One; 2014; 9(4):e95160. PubMed ID: 24740152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progranulin Decreases Susceptibility to
    Wang X; Yuan J; Wang H; Gan N; Zhang Q; Liu B; Wang J; Shu Z; Rao L; Gou X; Zhang H; Yin Y; Zhang X
    J Immunol; 2019 Oct; 203(8):2171-2182. PubMed ID: 31519865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.